These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. McEntee WJ, Mair RG. Science; 1978 Nov 24; 202(4370):905-7. PubMed ID: 715450 [Abstract] [Full Text] [Related]
3. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders. McEntee WJ, Mair RG, Langlais PJ. Neurology; 1984 May 24; 34(5):648-52. PubMed ID: 6200802 [Abstract] [Full Text] [Related]
4. Central nervous system catecholamine metabolism in Korsakoff's psychosis. Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH. Ann Neurol; 1984 Feb 24; 15(2):184-7. PubMed ID: 6200058 [Abstract] [Full Text] [Related]
5. Reduced concentrations of arginine vasopressin and MHPG in lumbar CSF of patients with Korsakoff's psychosis. Mair RG, Langlais PJ, Mazurek MF, Beal MF, Martin JB, McEntee WJ. Life Sci; 1986 Jun 23; 38(25):2301-6. PubMed ID: 2425205 [Abstract] [Full Text] [Related]
6. Multimodal sensory discrimination deficits in Korsakoff's psychosis. Mair RG, Doty RL, Kelly KM, Wilson CS, Langlais PJ, McEntee WJ, Vollmecke TA. Neuropsychologia; 1986 Jun 23; 24(6):831-9. PubMed ID: 2433640 [Abstract] [Full Text] [Related]
7. CSF monoamine metabolites in mania. Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW. Am J Psychiatry; 1983 Apr 23; 140(4):396-400. PubMed ID: 6188381 [Abstract] [Full Text] [Related]
8. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients. Linnoila M, Ninan PT, Scheinin M, Waters RN, Chang WH, Bartko J, van Kammen DP. Arch Gen Psychiatry; 1983 Dec 23; 40(12):1290-4. PubMed ID: 6197036 [Abstract] [Full Text] [Related]
9. Neurochemical specificity of learning: dopamine and motor learning. McEntee WJ, Mair RG, Langlais PJ. Yale J Biol Med; 1987 Dec 23; 60(2):187-93. PubMed ID: 2437709 [Abstract] [Full Text] [Related]
12. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M. Med Biol; 1985 Dec 23; 63(1):1-17. PubMed ID: 2582215 [Abstract] [Full Text] [Related]
13. Monoamine metabolites and ventricular fluid pressure in children. Yates CM, Minns RA. Childs Brain; 1981 Dec 23; 8(2):138-44. PubMed ID: 6166434 [Abstract] [Full Text] [Related]
14. Concentration gradients of monoamine metabolites in human cerebrospinal fluid. Sjöström R, Ekstedt J, Anggård E. J Neurol Neurosurg Psychiatry; 1975 Jul 23; 38(7):666-8. PubMed ID: 1159438 [Abstract] [Full Text] [Related]
15. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA. J Neurochem; 1984 Mar 23; 42(3):833-7. PubMed ID: 6198473 [Abstract] [Full Text] [Related]
16. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Garelis E, Young SN, Lal S, Sourkes TL. Brain Res; 1974 Oct 11; 79(1):1-8. PubMed ID: 4279131 [No Abstract] [Full Text] [Related]
17. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 11; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
18. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Sedvall GC, Wode-Helgodt B. Arch Gen Psychiatry; 1980 Oct 11; 37(10):1113-6. PubMed ID: 6158928 [Abstract] [Full Text] [Related]
19. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Oreland L, Wiberg A, Asberg M, Träskman L, Sjöstrand L, Thorén P, Bertilsson L, Tybring G. Psychiatry Res; 1981 Feb 11; 4(1):21-9. PubMed ID: 6164071 [Abstract] [Full Text] [Related]